Rocket


News + Filings
Transactions





Liu David Y

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
11/16/2022Protagonist Therapeutics, IncPTGXExerciseStock Option (right to buy)35.3k$4.21$148.7k 11/16/2022
11/16/2022Protagonist Therapeutics, IncPTGXExerciseStock Option (right to buy)35.7k$1.16$41.4k 11/16/2022
11/16/2022Protagonist Therapeutics, IncPTGXExerciseStock Option (right to buy)6k$1.89$11.3k 11/16/2022
11/16/2022Protagonist Therapeutics, IncPTGXExerciseStock Option (right to buy)9.7k$1.89$18.4k 11/16/2022
11/16/2022Protagonist Therapeutics, IncPTGXExerciseStock Option (right to buy)13.8k$0.87$12k 11/16/2022
02/28/2022Protagonist Therapeutics, IncPTGXPayment of ExerciseCommon Stock2.1k$24.28$51.4k 02/28/2022
02/15/2022Protagonist Therapeutics, IncPTGXGrantCommon Stock10k$0.00$0 02/15/2022
02/15/2022Protagonist Therapeutics, IncPTGXGrantStock Option (right to buy)60k$28.73$1.7M 02/15/2022
02/26/2021Protagonist Therapeutics, IncPTGXGrantStock Option (right to buy)65k$23.57$1.5M 02/26/2021
02/26/2021Protagonist Therapeutics, IncPTGXGrantCommon Stock10k$0.00$0 02/26/2021
02/28/2020Protagonist Therapeutics, IncPTGXGrantStock Option (right to buy)70k$7.80$546k 02/28/2020
08/06/2019Protagonist Therapeutics, IncPTGXSaleCommon Stock3.4k$8.85$30k 08/06/2019
03/01/2019Protagonist Therapeutics, IncPTGXSaleCommon Stock810$8.03$6.5k 02/28/2019
02/28/2019Protagonist Therapeutics, IncPTGXGrantEmployee Stock Option (right to buy)90k$8.02$721.8k 02/28/2019
02/28/2019Protagonist Therapeutics, IncPTGXGrantCommon Stock15k$0.00$0 02/28/2019
02/06/2019Protagonist Therapeutics, IncPTGXSaleCommon Stock3.8k$7.74$29.6k 02/06/2019
08/15/2018Protagonist Therapeutics, IncPTGXGrantCommon Stock25.8k$0.00$0 08/15/2018
08/15/2018Protagonist Therapeutics, IncPTGXGrantStock Option (right to buy)17.2k$8.58$147.6k 08/15/2018
03/12/2018Protagonist Therapeutics, IncPTGXSaleCommon Stock3.5k$21.29$74.5k 03/12/2018
03/12/2018Protagonist Therapeutics, IncPTGXExerciseEmployee Stock Option (right to buy)3.5k$4.21$14.7k 03/12/2018
03/02/2018Protagonist Therapeutics, IncPTGXExerciseEmployee Stock Option (right to buy)875$1.89$1.7k 02/28/2018
03/02/2018Protagonist Therapeutics, IncPTGXSaleCommon Stock875$20.00$17.5k 02/28/2018
02/28/2018Protagonist Therapeutics, IncPTGXGrantCommon Stock9.5k$0.00$0 02/28/2018
02/28/2018Protagonist Therapeutics, IncPTGXGrantEmployee Stock Option (right to buy)56.5k$16.95$957.7k 02/28/2018
01/16/2018Protagonist Therapeutics, IncPTGXExerciseEmployee Stock Option (right to buy)875$1.89$1.7k 01/16/2018
01/16/2018Protagonist Therapeutics, IncPTGXSaleCommon Stock875$20.00$17.5k 01/16/2018
12/18/2017Protagonist Therapeutics, IncPTGXSaleCommon Stock875$20.00$17.5k 12/18/2017
12/18/2017Protagonist Therapeutics, IncPTGXExerciseEmployee Stock Option (right to buy)875$1.89$1.7k 12/18/2017
11/30/2017Protagonist Therapeutics, IncPTGXGrantCommon Stock875$1.89$1.7k 11/30/2017
11/30/2017Protagonist Therapeutics, IncPTGXSaleCommon Stock875$20.00$17.5k 11/30/2017
11/30/2017Protagonist Therapeutics, IncPTGXExerciseEmployee Stock Option (right to buy)875$1.89$1.7k 11/30/2017
11/13/2017Protagonist Therapeutics, IncPTGXSaleCommon Stock3.5k$16.97$59.4k 11/13/2017
11/13/2017Protagonist Therapeutics, IncPTGXExerciseEmployee Stock Option (right to buy)3.5k$4.21$14.7k 11/13/2017
11/13/2017Protagonist Therapeutics, IncPTGXExerciseEmployee Stock Option (right to buy)3.5k$1.89$6.6k 11/13/2017

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy